ML050960460

From kanterella
Jump to navigation Jump to search
Transmittal of LaSalle County Station, Unit 2, Cycle 11 Core Operating Limits Report (COLR)
ML050960460
Person / Time
Site: LaSalle Constellation icon.png
Issue date: 03/30/2005
From: Landahl S
Exelon Generation Co, Exelon Nuclear
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
RA05-26
Download: ML050960460 (4)


Text

Exelkbn.m Exelon Generation Company, LLC www.exeloncorp.com NucleaT LaSalle County Station 2601 North 21"'Road Marseilles, IL 61341-97S7 RA05-26 March 30, 2005 United States Nuclear Regulatory Commission Attention: Document Control Desk Washington, D.C. 20555 LaSalle County Station, Unit 2 Facility Operating License No. NPF-18 NRC Docket No. 50-374

Subject:

Unit 2 Cycle 11 Core Operating Limits Report (COLR)

The purpose of this letter is to advise you of the Exelon Generation Company, LLC (EGC) review and approval of the LaSalle Unit 2 Cycle 11 reload under the provisions of 10 CFR 50.59, wChanges, tests and experiments," and to transmit the Core Operating Limits Report (COLR) for Cycle I1, consistent with Generic Letter 88-16, "Removal of Cycle-Specific Parameter Limits From Technical Specifications." This report is being submitted in accordance with LaSalle County Station Technical Specification 5.6.5, 'Core Operating Limits (COLR)," item d.

The reload licensing analyses performed for Cycle 11 utilized NRC approved methodologies.

The Unit 2 Cycle 11 core, which consists of NRC approved fuel designs developed by Global Nuclear Fuel (GNF) and Framatome Advanced Nuclear Fuel, Inc. (i.e., Framatome), was designed to operate within approved fuel design criteria provided in the Technical Specifications and related Bases. The core operating characteristics are bounded by the Updated Final Safety Analysis Report (UFSAR) allowable limits.

EGC has performed a review of the relevant reload licensing documents, associated Bases, and references in accordance with 10 CFR 50.59. The review process concluded that the reload does not require NRC review and approval.

Should you have any questions concerning this submittal, please contact Mr. Terrence W.

Simpkin, Regulatory Assurance Manager, at (815) 415-2800.

Respectfully,

)4~A R. /a(lY4 Susan R. Landahl Site Vice President LaSalle County Station Attachment cc: Regional Administrator - NRC Region IlIl NRC Senior Resident Inspector - LaSalle County Station

Affidavit Affidavit I, Margaret E. Harding, state as follows:

(1) I am Manager, Fuel Engineering Services, Global Nuclear Fuel - Americas, L.L.C. ("GNF-A") and have been delegated the function of reviewing the information described in paragraph (2) which is sought to be withheld, and have been authorized to apply for its withholding.

(2) The information sought to be withheld is contained in the attachment, "LaSalle Unit 2 Cycle 11 Core Operating Limits Report Revision 0." GNF proprietary information is indicated by enclosing it in double brackets and the text is red in color making it easily identifiable on a computer monitor. In each case, the superscript notation J3) refers to Paragraph (3) of this affidavit, which provides the basis for the proprietary determination.

(3) In making this application for withholding of proprietary information of which it is the owner or licensee, GNF-A relies upon the exemption from disclosure set forth in the Freedom of Information Act ("FOIA"), 5 USC Sec. 552(b)(4), and the Trade Secrets Act, 18 USC Sec. 1905, and NRC regulations 10 CFR 9.17(a)(4) and 2.390(a)(4) for "trade secrets and commercial or financial information obtained from a person and privileged or confidential" (Exemption 4). The material for which exemption from disclosure is here sought is all "confidential commercial information," and some portions also qualify under the narrower definition of "trade secret," within the meanings assigned to those terms for purposes of FOIA Exemption 4 in, respectively, Critical Mass Energy Project v. Nuclear Regulatory Commission, 975F2d871 (DC Cir. 1992), and Public Citizen Health Research Group v. FDA, 704F2dl280 (DC Cir. 1983).

(4) Some examples of categories of information which fit into the definition of proprietary information are:

a. Information that discloses a process, method, or apparatus, including supporting data and analyses, where prevention of its use by GNF-A's competitors without license from GNF-A constitutes a competitive economic advantage over other companies;
b. Information which, if used by a competitor, would reduce his expenditure of resources or improve his competitive position in the design, manufacture, shipment, installation, assurance of quality, or licensing of a similar product;
c. Information which reveals cost or price information, production capacities, budget levels, or commercial strategies of GNF-A, its customers, or its suppliers;
d. Information which reveals aspects of past, present, or future GNF-A customer-funded development plans and programs, of potential commercial value to GNF-A;

Affidavit

e. Information which discloses patentable subject matter for which it may be desirable to obtain patent protection.

The information sought to be withheld is considered to be proprietary for the reasons set forth in paragraphs (4)a. and (4)b., above.

(5) To address the 10 CFR 2.390 (b) (4), the information sought to be withheld is being submitted to NRC in confidence. The information is of a sort customarily held in confidence by GNF-A, and is in fact so held. Its initial designation as proprietary information, and the subsequent steps taken to prevent its unauthorized disclosure, are as set forth in (6) and (7) following. The information sought to be withheld has, to the best of my knowledge and belief, consistently been held in confidence by GNF-A, no public disclosure has been made, and it is not available in public sources. All disclosures to third parties including any required transmittals to NRC, have been made, or must be made, pursuant to regulatory provisions or proprietary agreements which provide for maintenance of the information in confidence.

(6) Initial approval of proprietary treatment of a document is made by the manager of the originating component, the person most likely to be acquainted with the value and sensitivity of the information in relation to industry knowledge, or subject to the terms under which it was licensed to GNF-A. Access to such documents within GNF-A is limited on a "need to know" basis.

(7) The procedure for approval of external release of such a document typically requires review by the staff manager, project manager, principal scientist or other equivalent authority, by the manager of the cognizant marketing function (or his delegate), and by the Legal Operation, for technical content, competitive effect, and determination of the accuracy of the proprietary designation. Disclosures outside GNF-A are limited to regulatory bodies, customers, and potential customers, and their agents, suppliers, and licensees, and others with a legitimate need for the information, and then only in accordance with appropriate regulatory provisions or proprietary agreements.

(8) The information identified in paragraph (2) is classified as proprietary because it contains details of GNF-A's fuel design and licensing methodology.

The development of the methods used in these analyses, along with the testing, development and approval of the supporting methodology was achieved at a significant cost, on the order of several million dollars, to GNF-A or its licensor.

(9) Public disclosure of the information sought to be withheld is likely to cause substantial harm to GNF-A's competitive position and foreclose or reduce the availability of profit-making opportunities. The fuel design and licensing methodology is part of GNF-A's comprehensive BWR safety and technology base, and its commercial value extends beyond the original development cost.

The value of the technology base goes beyond the extensive physical database and analytical methodology and includes development of the expertise to determine and apply the appropriate evaluation process. In addition, the technology base includes the value derived from providing analyses done with NRC-approved methods.

Affidavit The research, development, engineering, analytical, and NRC review costs comprise a substantial investment of time and money by GNF-A or its licensor.

The precise value of the expertise to devise an evaluation process and apply the correct analytical methodology is difficult to quantify, but it clearly is substantial.

GNF-A's competitive advantage will be lost if its competitors are able to use the results of the GNF-A experience to normalize or verify their own process or if they are able to claim an equivalent understanding by demonstrating that they can arrive at the same or similar conclusions.

The value of this information to GNF-A would be lost if the information were disclosed to the public. Making such information available to competitors without their having been required to undertake a similar expenditure of resources would unfairly provide competitors with a windfall, and deprive GNF-A of the opportunity to exercise its competitive advantage to seek an adequate return on its large investment in developing and obtaining these very valuable analytical tools.

I declare under penalty of perjury that the foregoing affidavit and the matters stated therein are true and correct to the best of my knowledge, information, and belief.

Executed at Wilmington, North Carolina, this 3rd day of March, 2005.

Nfargaret E. Harding Am a Global Nuclear Fuel - Amer~icas